Results 161 to 170 of about 8,569 (263)

Exploring the challenges faced by generic version of complex drugs: a scoping review. [PDF]

Syst Rev
Sreedevi A, Raj EA, Sreedhar D, Ligade VS.   +3 more
europepmc   +1 more source

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

Advanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li, Yunjie Lu, Ziyan Huang, Jianjiang Chen, Yanbin Liu, Lei Qin, Chao Wang, Yumin Wu   +7 more
wiley   +1 more source

Determinants of access to anticancer medicines in South Asia: a multimethod study. [PDF]

BMJ Open
Shukar S, Hussain I, Iqbal A, Rahimi A, Shirol GM, Shirzad I, Tenzin J, Dewan SMR, Kumari Mishra S, Saeed A, Babar ZU, Yang C, Fang Y.   +12 more
europepmc   +1 more source

Multidimensional and Multifunctional Laser‐Induced Graphene (LIG) for Point‐of‐Care and Wearable Biosensing, Theranostics, and Bioactive Interfaces Toward Personalized Healthcare and Regenerative Medicine

Advanced Science, EarlyView.
Multidimensional laser‐induced graphene (LIG) spanning from 0D to 3D architectures is comprehensively reviewed for multifunctional biomedical platforms, including biosensing, theranostics, and bioactive interface applications, which highlights its potentials for point‐of‐care diagnostics, wearable health monitoring, smart drug delivery, and tissue ...
Li Zhang, Yurou Yuan, Xiaohong Ding, Wing Cheung Mak   +3 more
wiley   +1 more source

Toponymic Generics I

Names, 1956
Meredith F. Burrill
doaj   +1 more source

Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis.

JAMA Health Forum
Li P, Klebanoff MJ, Lin JK, Doshi KD, Chahin S, Doshi JA.   +5 more
europepmc   +1 more source

Medicine affordability and access in India: lessons from generic-branded price variation under the Jan Aushadhi Scheme. [PDF]

Front Public Health
Behera DK, Rahut DB, Mehboobali MD, Tasneem SH, Rajendhran A.   +4 more
europepmc   +1 more source

Protein Structuromics Reveals a Loop‐Controlled Half‐Open Active Pocket Conformation Throughout Fe(II)/α‐ketoglutarate‐Dependent Dioxygenase Catalytic Cycle

Advanced Science, EarlyView.
This study reveals a conserved half‐open active pocket in Fe(II)/α‐ketoglutarate‐dependent dioxygenases through protein structuromics, distinguished by structural features comprising highly flexible loop elements. Enhanced sampling simulations‐guided mutagenesis experiments elucidated how this flexible loop regulates pocket open/closed conformations ...
Lunjie Wu, Huan Liu, Songyin Zhao, Lei Qin, Jiarui Li, Jun Wang, Zixuan Dai, Jie Gu, Yan Xu, Feiran Li, Yao Nie   +10 more
wiley   +1 more source

Toponymic Generics II

Names, 1956
Meredith F. Burrill
doaj   +1 more source

Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality. [PDF]

J Clin Med
Gómez Abreo D, Alarcón Cano DF, Ayala F, Belalcázar Carvajal N, Berrouet Mejía MC, Beltrán O, Calderón-Ospina CA, Castro-Salguero H, Escobar Cárdenas DM, Lema-Medina M, Marín Zuluaga JI, Milla Bernabé P, Niño Velasco RE, Osorio Estévez R, Ortiz JM, Rojas-Melo LJ, Urrego M, Vargas C, Zuluaga AF.   +18 more
europepmc   +1 more source